BioSpace News Archive

Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the third quarter of 2023.

Exagen Inc., a leading provider of autoimmune testing solutions, announced its participation in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, which takes place November 16th, 2023, at the Westin New York Grand Central Hotel in New York City.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will participate at several upcoming investor conferences.

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the third quarter ended September 30, 2023.

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, announced that it has acquired Electronic Registry Systems, Inc., a market leader in cancer registry software and services.

10x Genomics, Inc., a leader in single cell and spatial biology, reported financial results for the third quarter ended September 30, 2023.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third quarter ended September 30, 2023.

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2023.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 fourth quarter and full year ended September 30, 2023, before the opening of the market on Friday, November 17, 2023.

PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023.